ActinomycinD, 3A-(4-oxo-L-proline)- Actinomycin X2 Actinomycin X2
The Actinomycin V (8CI,9CI), with CAS registry number 18865-48-0, belongs to the following product category: Antibiotics. It has the systematic name of 2-amino-4,6-dimethyl-3-oxo-N1-[2,5,9-trimethyl-1,4,7,11,14,17-hexaoxo-6,13-di(propan-2-yl)hexadecahydro-1H-pyrrolo[2,1-i][1,4,7,10,13]oxatetraazacyclohexadecin-10-yl]-N9-[2,5,9-trimethyl-1,4,7,11, 14-pentaoxo-6,13-di(propan-2-yl)hexadecahydro-1H-pyrrolo[2,1-i][1,4,7,10,13]oxatetraazacyclohexadecin-10-yl]-3H-phenoxazine-1,9-dicarboxamide. This chemical should be stored at the temperature of 2-8°C. Its classification codes are Drug / Therapeutic Agent, Mutation data and Natural Product. And the chemical formula of this chemical is C62H84N12O17.
Physical properties of Actinomycin V (8CI,9CI): (1)ACD/LogP: -4.86; (2)# of Rule of 5 Violations: 3; (3)ACD/LogD (pH 5.5): -4.86; (4)ACD/LogD (pH 7.4): -4.87; (5)ACD/BCF (pH 5.5): 1; (6)ACD/BCF (pH 7.4): 1; (7)ACD/KOC (pH 5.5): 1; (8)ACD/KOC (pH 7.4): 1; (9)#H bond acceptors: 29; (10)#H bond donors: 6; (11)#Freely Rotating Bonds: 9; (12)Polar Surface Area: 314.67 Å2; (13)Index of Refraction: 1.661; (14)Molar Refractivity: 324.51 cm3; (15)Molar Volume: 877.8 cm3; (16)Polarizability: 128.64×10-24cm3; (17)Surface Tension: 55.1 dyne/cm; (18)Density: 1.44 g/cm3; (19)Flash Point: 807.4 °C; (20)Enthalpy of Vaporization: 216.11 kJ/mol; (21)Boiling Point: 1411.4 °C at 760 mmHg; (22)Vapour Pressure: 0 mmHg at 25°C.
When you are using this chemical, please be cautious about it as the following:
The Actinomycin V (8CI,9CI) irritates to eyes, respiratory system and skin. And it has possible risk of harm to the unborn child. When use it, wear suitable protective clothing, gloves and eye/face protection. If contact with eyes, rinse immediately with plenty of water and seek medical advice. In case of accident or if you feel unwell, seek medical advice immediately (show the label whenever possible.)
You can still convert the following datas into molecular structure:
(1)SMILES: c1(ccc(C)c2oc3c(nc12)c(c(c(c3C)=O)N)C(N[C@@H]1C(N[C@@H](C(N2[C@@H](C(N(CC(N([C@@H](C(O[C@@H]1C)=O)C(C)C)C)=O)C)=O)CC(C2)=O)=O)C(C)C)=O)=O)C(=O)N[C@@H]1C(=O)N[C@@H](C(N2[C@@H](C(N(C)CC(N([C@@H](C(C)C)C(=O)O[C@@H]1C)C)=O)=O)CCC2)=O)C(C)C
(2)InChI: InChI=1/C62H84N12O17/c1-26(2)42-59(85)73-21-17-18-36(73)57(83)69(13)24-38(76)71(15)48(28(5)6)61(87)89-32(11)44(55(81)65-42)67-53(79)35-20-19-30(9)51-46(35)64-47-40(41(63)50(78)31(10)52(47)91-51)54(80)68-45-33(12)90-62(88)49(29(7)8)72(16)39(77)25-70(14)58(84)37-22-34(75)23-74(37)60(86)43(27(3)4)66-56(45)82/h19-20,26-29,32-33,36-37,42-45,48-49H,17-18,21-25,63H2,1-16H3,(H,65,81)(H,66,82)(H,67,79)(H,68,80)
The toxicity data is as follows:
Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
---|---|---|---|---|---|
mouse | LD50 | intraperitoneal | 300ug/kg (0.3mg/kg) | Journal of Antibiotics. Vol. 38, Pg. 1625, 1985. | |
mouse | LD50 | intravenous | 1mg/kg (1mg/kg) | "CRC Handbook of Antibiotic Compounds," Vols.1- , Berdy, J., Boca Raton, FL, CRC Press, 1980Vol. 4(2), Pg. 48, 1980. | |
mouse | LD50 | subcutaneous | 300ug/kg (0.3mg/kg) | "Structure-Activity Relationship among the Semisynthetic Antibiotics," Perlman, D., ed., New York, Academic Press, 1977Vol. -, Pg. 427, 1977. |
The Actinomycin V (8CI,9CI), with CAS registry number 18865-48-0, belongs to the following product category: Antibiotics. It has the systematic name of 2-amino-4,6-dimethyl-3-oxo-N1-[2,5,9-trimethyl-1,4,7,11,14,17-hexaoxo-6,13-di(propan-2-yl)hexadecahydro-1H-pyrrolo[2,1-i][1,4,7,10,13]oxatetraazacyclohexadecin-10-yl]-N9-[2,5,9-trimethyl-1,4,7,11, 14-pentaoxo-6,13-di(propan-2-yl)hexadecahydro-1H-pyrrolo[2,1-i][1,4,7,10,13]oxatetraazacyclohexadecin-10-yl]-3H-phenoxazine-1,9-dicarboxamide. This chemical should be stored at the temperature of 2-8°C. Its classification codes are Drug / Therapeutic Agent, Mutation data and Natural Product. And the chemical formula of this chemical is C62H84N12O17.
Physical properties of Actinomycin V (8CI,9CI): (1)ACD/LogP: -4.86; (2)# of Rule of 5 Violations: 3; (3)ACD/LogD (pH 5.5): -4.86; (4)ACD/LogD (pH 7.4): -4.87; (5)ACD/BCF (pH 5.5): 1; (6)ACD/BCF (pH 7.4): 1; (7)ACD/KOC (pH 5.5): 1; (8)ACD/KOC (pH 7.4): 1; (9)#H bond acceptors: 29; (10)#H bond donors: 6; (11)#Freely Rotating Bonds: 9; (12)Polar Surface Area: 314.67 Å2; (13)Index of Refraction: 1.661; (14)Molar Refractivity: 324.51 cm3; (15)Molar Volume: 877.8 cm3; (16)Polarizability: 128.64×10-24cm3; (17)Surface Tension: 55.1 dyne/cm; (18)Density: 1.44 g/cm3; (19)Flash Point: 807.4 °C; (20)Enthalpy of Vaporization: 216.11 kJ/mol; (21)Boiling Point: 1411.4 °C at 760 mmHg; (22)Vapour Pressure: 0 mmHg at 25°C.
When you are using this chemical, please be cautious about it as the following:
The Actinomycin V (8CI,9CI) irritates to eyes, respiratory system and skin. And it has possible risk of harm to the unborn child. When use it, wear suitable protective clothing, gloves and eye/face protection. If contact with eyes, rinse immediately with plenty of water and seek medical advice. In case of accident or if you feel unwell, seek medical advice immediately (show the label whenever possible.)
You can still convert the following datas into molecular structure:
(1)SMILES: c1(ccc(C)c2oc3c(nc12)c(c(c(c3C)=O)N)C(N[C@@H]1C(N[C@@H](C(N2[C@@H](C(N(CC(N([C@@H](C(O[C@@H]1C)=O)C(C)C)C)=O)C)=O)CC(C2)=O)=O)C(C)C)=O)=O)C(=O)N[C@@H]1C(=O)N[C@@H](C(N2[C@@H](C(N(C)CC(N([C@@H](C(C)C)C(=O)O[C@@H]1C)C)=O)=O)CCC2)=O)C(C)C
(2)InChI: InChI=1/C62H84N12O17/c1-26(2)42-59(85)73-21-17-18-36(73)57(83)69(13)24-38(76)71(15)48(28(5)6)61(87)89-32(11)44(55(81)65-42)67-53(79)35-20-19-30(9)51-46(35)64-47-40(41(63)50(78)31(10)52(47)91-51)54(80)68-45-33(12)90-62(88)49(29(7)8)72(16)39(77)25-70(14)58(84)37-22-34(75)23-74(37)60(86)43(27(3)4)66-56(45)82/h19-20,26-29,32-33,36-37,42-45,48-49H,17-18,21-25,63H2,1-16H3,(H,65,81)(H,66,82)(H,67,79)(H,68,80)
The toxicity data is as follows:
Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
---|---|---|---|---|---|
mouse | LD50 | intraperitoneal | 300ug/kg (0.3mg/kg) | Journal of Antibiotics. Vol. 38, Pg. 1625, 1985. | |
mouse | LD50 | intravenous | 1mg/kg (1mg/kg) | "CRC Handbook of Antibiotic Compounds," Vols.1- , Berdy, J., Boca Raton, FL, CRC Press, 1980Vol. 4(2), Pg. 48, 1980. | |
mouse | LD50 | subcutaneous | 300ug/kg (0.3mg/kg) | "Structure-Activity Relationship among the Semisynthetic Antibiotics," Perlman, D., ed., New York, Academic Press, 1977Vol. -, Pg. 427, 1977. |
About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia
Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog
©2008 LookChem.com,License: ICP
NO.:Zhejiang16009103
complaints:service@lookchem.com Desktop View